Skip to main content

Thank you for visiting nature.com. You are using a browser version with limited support for CSS. To obtain the best experience, we recommend you use a more up to date browser (or turn off compatibility mode in Internet Explorer). In the meantime, to ensure continued support, we are displaying the site without styles and JavaScript.

  • News & Views
  • Published:

Diabetes

Bardoxolone improves kidney function in type 2 diabetes

Nature Reviews Nephrology volume 7, pages 552–553 (2011)Cite this article

Subjects

Recent clinical studies with bardoxolone methyl have demonstrated improvements in the glomerular filtration rate of diabetic patients with chronic kidney disease (CKD). Although its mechanism of action is uncertain, the persisting effects of bardoxolone methyl in this challenging group of patients are a source of optimism for the management of CKD.

This is a preview of subscription content, access via your institution

Access options

Buy this article

  • Purchase on Springer Link
  • Instant access to full article PDF
Buy now

Prices may be subject to local taxes which are calculated during checkout

References

  1. US Renal Data System. USRDS 2004 Annual Data Report: Atlas of End-Stage Renal Disease in the United States [online], (2004).

  2. Pergola, P. E. et al. Effect of bardoxolone methyl on kidney function in patients with T2D and Stage 3b-4 CKD. Am. J. Nephrol. 33, 469–476 (2011).

    Article  CAS  Google Scholar 

  3. Jiang, T. et al. The protective role of Nrf2 in streptozotocin-induced diabetic nephropathy. Diabetes 59, 850–860 (2010).

    Article  CAS  Google Scholar 

  4. Yoh, K. et al. Hyperglycemia induces oxidative and nitrosative stress and increases renal functional impairment in Nrf2-deficient mice. Genes Cells 13, 1159–1170 (2008).

    CAS  PubMed  Google Scholar 

  5. Ungvari, Z. et al. Adaptive induction of NF-E2-related factor-2-driven antioxidant genes in endothelial cells in response to hyperglycemia. Am. J. Physiol. Heart Circ. Physiol. 300, H1133–H1140 (2011).

    Article  CAS  Google Scholar 

  6. Xue, M. et al. Activation of NF-E2-related factor-2 reverses biochemical dysfunction of endothelial cells induced by hyperglycemia linked to vascular disease. Diabetes 57, 2809–2817 (2008).

    Article  CAS  Google Scholar 

  7. Meyer, C. J. Bardoxolone, a novel oral anti-inflammatory agent shown to improve renal function [abstract]. Am. J. Kidney Dis. 53, a129 (2009).

    Google Scholar 

  8. Wang, H. et al. Heme oxygenase metabolites inhibit tubuloglomerular feedback in vivo. Am. J. Physiol. Heart Circ. Physiol. 300, H1320–H1326 (2011).

    Article  CAS  Google Scholar 

  9. US National Library of Medicine. ClinicalTrials.gov [online], (2011).

  10. Brenner, B. M. et al. Effects of losartan on renal and cardiovascular outcomes in patients with type 2 diabetes and nephropathy. N. Engl. J. Med. 345, 861–869 (2001).

    Article  CAS  Google Scholar 

Download references

Author information

Authors and Affiliations

  1. Baker IDI Heart and Diabetes Institute, PO Box 6492, St Kilda Road Central, Melbourne, 8008, Vic, Australia

    Merlin C. Thomas & Mark E. Cooper

Authors
  1. Merlin C. Thomas
    View author publications

    You can also search for this author in PubMed Google Scholar

  2. Mark E. Cooper
    View author publications

    You can also search for this author in PubMed Google Scholar

Corresponding author

Correspondence to Mark E. Cooper.

Ethics declarations

Competing interests

M. C. Thomas has received speakers bureau honoraria from Abbott. M. E. Cooper has worked as a consultant for Abbott.

Rights and permissions

Reprints and permissions

About this article

Cite this article

Thomas, M., Cooper, M. Bardoxolone improves kidney function in type 2 diabetes. Nat Rev Nephrol 7, 552–553 (2011). https://doi.org/10.1038/nrneph.2011.114

Download citation

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1038/nrneph.2011.114

This article is cited by

Search

Advanced search

Quick links

Nature Briefing

Sign up for the Nature Briefing newsletter — what matters in science, free to your inbox daily.

Get the most important science stories of the day, free in your inbox. Sign up for Nature Briefing